INIS
lungs
100%
pathology
100%
macrophages
100%
inflammation
100%
accumulation
100%
lipids
100%
density
37%
enzymes
37%
lipoproteins
37%
mice
25%
production
25%
in vivo
25%
in vitro
25%
interleukins
25%
prostaglandins
25%
foams
25%
diseases
12%
surfactants
12%
pneumonia
12%
receptors
12%
stimulation
12%
interstitials
12%
defects
12%
adhesion
12%
tumor necrosis factor
12%
granulocytes
12%
enzyme activity
12%
cell membranes
12%
phospholipids
12%
nitric oxide
12%
incubation
12%
phosphatidylcholine
12%
Medicine and Dentistry
Macrophage
100%
Lipid Storage
100%
Serositis
100%
Anti-Inflammatory Drug
100%
Pulmonary Pathology
100%
Secretory Phospholipase A2
100%
Phospholipase A
100%
Phospholipase A2 Group X
100%
In Vitro
16%
Low-Density Lipoprotein
16%
Foam Cell
16%
Nitric Oxide
8%
Tumor Necrosis Factor
8%
Interleukin 6
8%
Pneumonia
8%
Cell Membrane
8%
Prostaglandin E
8%
Phospholipid
8%
Interleukin 10
8%
Oxidized Low Density Lipoprotein
8%
Incubation
8%
Macrophage Activation
8%
Atherogenesis
8%
Scavenger Receptor
8%
Enzyme Activity
8%
Cell Adhesion
8%
Granulocyte
8%
Idiopathic Interstitial Pneumonia
8%
Prostaglandin
8%
Egg Lecithin
8%
Surfactant
8%
Keyphrases
Macrophages
100%
Lipid Accumulation
100%
SPLA2
100%
Lung Pathology
100%
Anti-inflammatory Response
100%
A2-groups
100%
Inflammatory Response
16%
Overexpression
16%
Transgenic
16%
Foam Cell Formation
16%
Interleukin-6
8%
Enhanced Production
8%
Tumor Necrosis Factor-α
8%
Surfactant
8%
Cell Adhesion
8%
Interleukin-10
8%
Granulocytes
8%
Enzyme Activity
8%
Chronic Inflammatory Diseases
8%
In Vitro Activity
8%
Cell Membrane
8%
Overexpressing
8%
Macrophage Infiltration
8%
Incubation
8%
Phosphatidylcholine
8%
Atherogenesis
8%
Low-density Lipoprotein
8%
Oxidized Low-density Lipoprotein (ox-LDL)
8%
Inflammatory Macrophages
8%
Prostaglandin E2
8%
Phospholipids
8%
Prostaglandins
8%
Lipolytic Enzymes
8%
Enzyme Family
8%
Nitric Oxide Production
8%
Reduced Activation
8%
Enhanced Expression
8%
Scavenger Receptor CD36
8%
Reduced Cell
8%
Macrophage Activation
8%
Phospholipase A2 (PLA2)
8%
Inflammatory Lung Disease
8%
High Catalytic Activity
8%
Interstitial Pneumonia
8%
Enhanced Foam
8%
Native Low-density Lipoprotein
8%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Anti-Inflammatory Drug
100%
Phospholipase A
100%
Secretory Phospholipase A2
100%
Phospholipase A2 Group X
100%
Low Density Lipoprotein
16%
Interleukin 6
8%
Nitric Oxide
8%
Tumor Necrosis Factor
8%
Pneumonia
8%
Prostaglandin
8%
Phospholipid
8%
Interleukin 10
8%
Oxidized Low Density Lipoprotein
8%
Scavenger Receptor
8%
Surfactant
8%
Prostaglandin E
8%
Atherogenesis
8%
Interstitial Pneumonia
8%
Egg Lecithin
8%
Immunology and Microbiology
Macrophage
100%
Lipid Storage
100%
Inflammation Response
100%
Foam Cell
28%
Transgenics
28%
Interleukin 6
14%
Enzyme Activity
14%
Tumor Necrosis Factor
14%
Prostaglandin E
14%
Interleukin 10
14%
CD36
14%
Macrophage Activation
14%
Scavenger Receptor
14%
Cell Membrane
14%
Cell Adhesion
14%
Prostaglandin
14%
Granulocyte
14%
Biochemistry, Genetics and Molecular Biology
Polymorphonuclear Cell
8%